Antidepressant-like effects of piperine and its derivative, antiepilepsirine

Journal of Asian Natural Products Research

Volumn 9, Issue 5, 2007, Pages 421-430

  Li, Song ^a   Wang, Che ^a   Li, Wei ^b   Koike, Kazuo ^b   Nikaido, Tamatsu ^b   Wang, Min Wei ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b TOHO UNIVERSITY   (Japan)

Author keywords

Antidepressant; Antiepilepsirine; MAO activity; Monoamine; Piperine

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANTIEPILEPSIRINE; DOPAMINE; FLUOXETINE; NORADRENALIN; PIPERINE; SEROTONIN; 1,3 BENZODIOXOLE DERIVATIVE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ALKALOID; AMIDE; ANTIDEPRESSANT AGENT; BIOGENIC AMINE; MONOAMINE OXIDASE INHIBITOR; PIPERIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN REGION; CONTROLLED STUDY; DEPRESSION; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; EXPERIMENTAL TEST; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MALE; MOUSE; NEUROTRANSMITTER UPTAKE; NONHUMAN; NORADRENALIN BRAIN LEVEL; OPEN FIELD TEST; SEROTONIN BRAIN LEVEL; SEROTONINERGIC SYSTEM; TAIL SUSPENSION TEST; ANIMAL; INSTITUTE FOR CANCER RESEARCH MOUSE; MOTOR ACTIVITY;

ALKALOIDS; ANIMALS; ANTIDEPRESSIVE AGENTS; BENZODIOXOLES; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; FLUOXETINE; MALE; MICE; MICE, INBRED ICR; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; NEUROTRANSMITTER AGENTS; PIPERIDINES; POLYUNSATURATED ALKAMIDES;

EID: 38449093258     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020500384302     Document Type: Article

References (30)

1. R. Kessler, K.A. McGonagle, S. Zhao. Arch. Gen. Psychiatry, 51, 8 (1994).
2. R. Duman, J. Malberg, S. Nakagawa. Biol. Psychiatry, 48, 732 (2000).
3. M.L. Wong, J. Licinio. Nat. Rev. Neurosci., 2, 343 (2001).
4. W.E. Müller. Pharmacol. Res., 47, 101 (2003).
5. I. Hindmarch. Eur. Psychiatry, 17(Suppl. 3), 294 (2002).
6. I. Malagië, D.J. David, P. Jolliet, R. Hen, M. Bourin, A.M. Gardier. Eur. J. Pharmacol., 443, 99 (2002).
7. J.A. Gordon, R. Hen. Annu. Rev. Neurosci., 27, 193 (2004).
8. Y.M. Wang, F. Xu, R.R. Gainetdinov, M.G. Caron. Biol. Psychiatry, 46, 1124 (1999).
9. N. Brunello, P. Blier, L.L. Judd, J. Mendlewicz, C.J. Nelson, D. Souery, J. Zohar, G. Racagni. Int. Clin. Psychopharmacol., 18, 191 (2003).
10. H.A. D'haenen, A. Bossuyt. Biol. Psychiatry, 35, 128 (1994).
11. L. Cervo, G. Grignaschi, R. Samanin. Eur. J. Pharmacol., 178, 129 (1990).
12. C.E. Renard, A.J. Fiocco, F. Clenet, M. Hascoet, M. Bourin. Psychopharmacology, 159, 42 (2001).
13. L. Steru, R. Chermat, B. Thierry. Psychopharmacology, 85, 367 (1985).
14. R.D. Porsolt, A. Bertin, M. Jalfre. Arch. Int. Pharmacodyn. Ther., 229, 327 (1977).
15. Y.Q. Pei. Epilepsia, 24, 177 (1983).
16. F.P. Bymaster, W. Zhang, P.A. Carter. Psychopharmacology, 160, 353 (2002).
17. P. Blier, F.V. Abbott. J. Psychiatry Neurosci., 26, 37 (2001).
18. E. Dailly, F. Chenu, C.E. Renard. Fund. Clin. Pharmacol., 18, 601 (2004).
19. D.T. Wong, F.P. Bymaster. Prog. Drug Res., 58, 169 (2002).
20. H. Saito, M. Matsumoto, H. Togashi, M. Yoshioka. Jpn. J. Pharmacol., 70, 203 (1996).
21. J.M. Baraban, G.K. Aghajanian. Brain Res., 204, 1 (1981).
22. Z.A. Hughes, S.C. Stanford. Eur. J. Pharmacol., 317, 83 (1996).
23. L. Pozzi, R. Invernizzi, C. Garavaglia, R. Samanin. J. Neurochem., 73, 1051 (1999).
24. K. Wei, W. Li, K. Koike. J. Nat. Prod., 67, 1005 (2004).
25. L.D. Kong, C.H. Cheng, R.X. Tan. J. Ethnopharmacol., 91, 351 (2004).
26. J. Archer. Anim. Behav., 21, 205 (1973).
27. L.K. Zhang, X.Y. Niu, Y.W. Yu. Acta Pharm. Sin., 22, 591 (1987).
28. A. Schurr, A. Livne. Biochem. Pharmacol., 25, 1201 (1976).
29. Z.F. Yu, L.D. Kong, Y. Chen. J. Ethnopharmacol., 83, 161 (2002).
30. O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall. J. Biol. Chem., 193, 265 (1951).